SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-006396
Filing Date
2024-01-25
Accepted
2024-01-25 06:02:10
Documents
1
Period of Report
2024-01-22

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm243935-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm243935-2_4seq1.xml 4 6125
  Complete submission text file 0001104659-24-006396.txt   7924
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Issuer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O STEMLINE THERAPEUTICS, INC. 750 LEXINGTON AVENUE, 11TH FLOOR NEW YORK NY 10022
Business Address
Francomano Robert (Reporting) CIK: 0001797467 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33958 | Film No.: 24558456